194 related articles for article (PubMed ID: 26375816)
21. Molecular pathological classification of colorectal cancer.
Müller MF; Ibrahim AE; Arends MJ
Virchows Arch; 2016 Aug; 469(2):125-34. PubMed ID: 27325016
[TBL] [Abstract][Full Text] [Related]
22. Impact of chromosomal instability on colorectal cancer progression and outcome.
Orsetti B; Selves J; Bascoul-Mollevi C; Lasorsa L; Gordien K; Bibeau F; Massemin B; Paraf F; Soubeyran I; Hostein I; Dapremont V; Guimbaud R; Cazaux C; Longy M; Theillet C
BMC Cancer; 2014 Feb; 14():121. PubMed ID: 24559140
[TBL] [Abstract][Full Text] [Related]
23. Multigene Panel Sequencing Reveals Cancer-Specific and Common Somatic Mutations in Colorectal Cancer Patients: An Egyptian Experience.
Youssef ASE; Abdel-Fattah MA; Lotfy MM; Nassar A; Abouelhoda M; Touny AO; Hassan ZK; Mohey Eldin M; Bahnassy AA; Khaled H; Zekri ARN
Curr Issues Mol Biol; 2022 Mar; 44(3):1332-1352. PubMed ID: 35723313
[TBL] [Abstract][Full Text] [Related]
24. Tumour break load is a biologically relevant feature of genomic instability with prognostic value in colorectal cancer.
Lakbir S; Lahoz S; Cuatrecasas M; Camps J; Glas RA; Heringa J; Meijer GA; Abeln S; Fijneman RJA
Eur J Cancer; 2022 Dec; 177():94-102. PubMed ID: 36334560
[TBL] [Abstract][Full Text] [Related]
25. Molecular dissection of premalignant colorectal lesions reveals early onset of the CpG island methylator phenotype.
Yamamoto E; Suzuki H; Yamano HO; Maruyama R; Nojima M; Kamimae S; Sawada T; Ashida M; Yoshikawa K; Kimura T; Takagi R; Harada T; Suzuki R; Sato A; Kai M; Sasaki Y; Tokino T; Sugai T; Imai K; Shinomura Y; Toyota M
Am J Pathol; 2012 Nov; 181(5):1847-61. PubMed ID: 22995252
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the prevalence of KRAS-LCS6 polymorphism (rs61764370) within different tumour types (colorectal, breast, non-small cell lung cancer and brain tumours). A study of the Czech population.
Uvirova M; Simova J; Kubova B; Dvorackova N; Tomaskova H; Sedivcova M; Dite P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Sep; 159(3):466-71. PubMed ID: 26077004
[TBL] [Abstract][Full Text] [Related]
27. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.
Yurgelun MB; Masciari S; Joshi VA; Mercado RC; Lindor NM; Gallinger S; Hopper JL; Jenkins MA; Buchanan DD; Newcomb PA; Potter JD; Haile RW; Kucherlapati R; Syngal S;
JAMA Oncol; 2015 May; 1(2):214-21. PubMed ID: 26086041
[TBL] [Abstract][Full Text] [Related]
28. Establishment and characterization of cell lines from chromosomal instable colorectal cancer.
Maletzki C; Gock M; Randow M; Klar E; Huehns M; Prall F; Linnebacher M
World J Gastroenterol; 2015 Jan; 21(1):164-76. PubMed ID: 25574089
[TBL] [Abstract][Full Text] [Related]
29. Combined assessment of epidermal [corrected] growth factor receptor dual color in situ hybridization and immunohistochemistry with downstream gene mutations in prediction of response to the anti-EGFR therapy for patients with metastatic colorectal cancer.
Takahashi N; Yamada Y; Taniguchi H; Honma Y; Iwasa S; Kato K; Hamaguchi T; Shimada Y
Arch Med Res; 2014 Jul; 45(5):366-74. PubMed ID: 24830936
[TBL] [Abstract][Full Text] [Related]
30. Relationship between point gene mutation, chromosomal abnormality, and tumour suppressor gene methylation status in colorectal adenomas.
Judson H; Stewart A; Leslie A; Pratt NR; Baty DU; Steele RJ; Carey FA
J Pathol; 2006 Nov; 210(3):344-50. PubMed ID: 16902913
[TBL] [Abstract][Full Text] [Related]
31. Multiregion ultra-deep sequencing reveals early intermixing and variable levels of intratumoral heterogeneity in colorectal cancer.
Suzuki Y; Ng SB; Chua C; Leow WQ; Chng J; Liu SY; Ramnarayanan K; Gan A; Ho DL; Ten R; Su Y; Lezhava A; Lai JH; Koh D; Lim KH; Tan P; Rozen SG; Tan IB
Mol Oncol; 2017 Feb; 11(2):124-139. PubMed ID: 28145097
[TBL] [Abstract][Full Text] [Related]
32. Chromosomal changes in colorectal adenomas: relationship to gene mutations and potential for clinical utility.
Leslie A; Stewart A; Baty DU; Mechan D; McGreavey L; Smith G; Wolf CR; Sales M; Pratt NR; Steele RJ; Carey FA
Genes Chromosomes Cancer; 2006 Feb; 45(2):126-35. PubMed ID: 16235243
[TBL] [Abstract][Full Text] [Related]
33. [Crohn's disease-associated colorectal carcinogenesis : TP53 mutations and copy number gains of chromosome arm 5p as (early) markers of tumor progression].
Hirsch D; Gaiser T
Pathologe; 2018 Dec; 39(Suppl 2):253-261. PubMed ID: 30229283
[TBL] [Abstract][Full Text] [Related]
34. Poor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instability.
Umeda Y; Nagasaka T; Mori Y; Sadamori H; Sun DS; Shinoura S; Yoshida R; Satoh D; Nobuoka D; Utsumi M; Yoshida K; Yagi T; Fujiwara T
J Hepatobiliary Pancreat Sci; 2013 Feb; 20(2):223-33. PubMed ID: 23010994
[TBL] [Abstract][Full Text] [Related]
35. Copy number alterations of chromosomal regions enclosing protein tyrosine phosphatase receptor-like genes in colorectal cancer.
Laczmanska I; Karpinski P; Kozlowska J; Bebenek M; Ramsey D; Sedziak T; Ziolkowski P; Sasiadek MM
Pathol Res Pract; 2014 Dec; 210(12):893-6. PubMed ID: 25169130
[TBL] [Abstract][Full Text] [Related]
36.
Siraj AK; Masoodi T; Bu R; Pratheeshkumar P; Al-Sanea N; Ashari LH; Abduljabbar A; Alhomoud S; Al-Dayel F; Alkuraya FS; Al-Kuraya KS
Gut; 2018 Apr; 67(4):663-671. PubMed ID: 28183795
[TBL] [Abstract][Full Text] [Related]
37. KRAS mutations are associated with inferior clinical outcome in patients with metastatic colorectal cancer, but are not predictive for benefit with cediranib.
Smith JC; Brooks L; Hoff PM; McWalter G; Dearden S; Morgan SR; Wilson D; Robertson JD; Jürgensmeier JM
Eur J Cancer; 2013 Jul; 49(10):2424-32. PubMed ID: 23510802
[TBL] [Abstract][Full Text] [Related]
38. Integrative genomics reveals mechanisms of copy number alterations responsible for transcriptional deregulation in colorectal cancer.
Camps J; Nguyen QT; Padilla-Nash HM; Knutsen T; McNeil NE; Wangsa D; Hummon AB; Grade M; Ried T; Difilippantonio MJ
Genes Chromosomes Cancer; 2009 Nov; 48(11):1002-17. PubMed ID: 19691111
[TBL] [Abstract][Full Text] [Related]
39. Large Bowel Genetic Background and Inflammatory Processes in Carcinogenesis--Systematic Review.
Szylberg Ł; Janiczek M; Popiel A; Marszałek A
Adv Clin Exp Med; 2015; 24(4):555-63. PubMed ID: 26469098
[TBL] [Abstract][Full Text] [Related]
40. Clinical relevance of alterations in quantity and quality of plasma DNA in colorectal cancer patients: based on the mutation spectra detected in primary tumors.
Lin JK; Lin PC; Lin CH; Jiang JK; Yang SH; Liang WY; Chen WS; Chang SC
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S680-6. PubMed ID: 24841357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]